Acute Promyelocytic Leukemia: High Risk and Relapsed APL

被引:0
|
作者
Lengfelder, E. [1 ]
Hecht, A. [1 ]
Nowak, D. [1 ]
Nolte, F. [1 ]
Hofmann, W. -K. [1 ]
机构
[1] Med Coll Penn & Hahnemann Univ, Dept Hematol & Oncol, Heidelberg, Germany
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:34 / 35
页数:2
相关论文
共 50 条
  • [1] Acute Promyelocytic Leukemia: High Risk and Relapsed APL
    Lengfelder, E.
    Hecht, A.
    Nowak, D.
    Nolte, F.
    Hofmann, W. -K.
    ANNALS OF HEMATOLOGY, 2015, 94 : S34 - S35
  • [2] Synchronous Diagnosis of Acute Promyelocytic Leukemia (APL) and Relapsed Breast Cancer (RBC)
    Rasmaoui, Asmae
    Lamchahab, Mouna
    Benazzouz, Hamza
    Oukkache, Bouchra
    Hda, Nazha
    Benmoussa, Amine
    Qachouh, Meryem
    Rachid, Mohamed
    Cherkaoui, Siham
    Khoubila, Nissrine
    Madani, Abdellah
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S326 - S327
  • [3] Efficacy of Gemtuzumab Ozogamicin (GO) Monotherapy on Relapsed/Refractory Acute Promyelocytic Leukemia (APL)
    Takeshita, Akihiro
    Ono, Takaaki
    Kojima, Yumi
    Kyo, Taiichi
    Asou, Norio
    Suzushima, Hitoshi
    Yagasaki, Fumiharu
    Maeda, Tomoya
    Okada, Masaya
    Nakaseko, Chiaki
    Kanbayashi, Hiroyuki
    Yamaguchi, Masaki
    Kurosawa, Mitsutoshi
    Tsuboi, Kosuke
    Yujiri, Toshiaki
    Nannya, Yasuhito
    Uike, Naokuni
    Akiyama, Nobu
    Fukuda, Tetsuya
    Karimata, Kaori
    Okumura, Hirokazu
    Eto, Tetsuya
    Izumiyama, Koh
    Watanabe, Akihiro
    Aotsuka, Nobuyuki
    Ito, Katsuro
    Ozaki, Keiji
    Naoe, Tomoki
    BLOOD, 2011, 118 (21) : 665 - 666
  • [4] Pharmacokinetics of arsenic trioxide (ATO) in patients with relapsed/refractory acute promyelocytic leukemia (APL).
    Soignet, S
    Bienvenu, B
    Warrell, RP
    Ellisson, R
    Spriggs, D
    Brannan, M
    CLINICAL CANCER RESEARCH, 2000, 6 : 4534S - 4534S
  • [5] ACUTE PROMYELOCYTIC LEUKEMIA (APL) PRESENTING WITH ACUTE STROKE
    Chaudhari, D.
    Renjen, P.
    Jain, S.
    Mishra, A.
    Sahu, N.
    INTERNATIONAL JOURNAL OF STROKE, 2022, 17 (3_SUPPL) : 258 - 258
  • [6] Morphologic heterogeneity of acute promyelocytic leukemia (APL)
    Sinha, S
    Aish, L
    Oo, TH
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 618S - 618S
  • [7] Acute Promyelocytic Leukemia (APL): The Kuwait Experience
    Alhuraiji, Ahmad
    Salem, Nermin
    Naim, Faran
    Ram, Mohan
    Kunhikrishnan, Anitha
    Alshemmari, Salem
    Hamadah, Abdulaziz
    Hassaneen, Mahmoud
    Galal, Rasha
    Shah, Abdul Rashid
    Khadadah, Fatima
    Pandita, Ramesh
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S286 - S287
  • [8] MULTIPARAMETER IMMUNOPHENOTYPE OF ACUTE PROMYELOCYTIC LEUKEMIA (APL)
    FRANKEL, SR
    LI, K
    BAER, MR
    STEWART, CC
    DAVEY, F
    REGAL, L
    LAWRENCE, D
    SCHIFFER, CA
    BLOOMFIELD, CD
    BLOOD, 1994, 84 (10) : A309 - A309
  • [9] Treatment of Molecular and Clinical Relapse of Acute Promyelocytic Leukemia (APL) with Arsenic Trioxide: Results of the European Registry of Relapsed APL
    Lengfelder, Eva
    Lo-Coco, Francesco
    Montesinos, Pau
    Grimwade, David
    Ades, Lionel
    Kishore, Bhuvan
    Pagoni, Maria
    Ramadan, Safaa M.
    Breccia, Massimo
    Holowiecka, Alexandra
    Pradel, Anne
    Sauerland, Maria Cristina
    Fenaux, Pierre
    Angel Sanz, Miguel
    BLOOD, 2010, 116 (21) : 12 - 12
  • [10] A High Prevalence of Obesity in Acute Promyelocytic Leukemia (APL): Is Obesity a Risk Factor for APL? Implication of Targeted Therapy to Control Obesity and APL Prevention
    Qualtieri, Julianne
    Tedesco, Jason
    Savani, Bipin N.
    Ayers, Gregory
    Kumar, Meera
    Greer, John P.
    Head, David R.
    Reddy, Nishitha
    BLOOD, 2009, 114 (22) : 1205 - 1205